Patents Assigned to Catalent Pharma Solutions, Inc.
  • TWIN-SCREW DRY GRANULATION FOR PRODUCING SOLID FORMULATIONS
    Publication number: 20170319486
    Abstract: A dry granulation process using a twin-screw extruder for granulating a powder mixture which includes at least one active ingredient and at least one carrier. The process includes steps of kneading the powder mixture in the screw barrel of the twin-screw extruder at a barrel temperature below a melting point of the at least one active ingredient and a melting point or a glass transition temperature of the at least one carrier to provide a kneaded powder mixture, and extruding the kneaded powder mixture to form granules. Granules and tablets produced using the dry granulation process in the twin-screw extruder are also provided.
    Type: Application
    Filed: April 21, 2017
    Publication date: November 9, 2017
    Applicants: CATALENT PHARMA SOLUTIONS INC., UNIVERSITY OF MISSISSIPPI
    Inventors: Sampada Bhaskar UPADHYE, Ronald S. VLADYKA, R.ph, Michael Andrew REPKA, Jun-Bom PARK, Roshan Vijay TIWARI, Hemlata Gunga PATIL, Joseph Thomas MOROTT, JR., Wenli LU
  • Fusion antibodies
    Patent number: 9541547
    Abstract: The present invention provides novel antibodies. In particular, the present invention provides fusion antibodies comprising antibody heavy and light chain fusions. The present invention further provides multivalent antibodies comprising multiple fusion antibody chains. The present invention further provides methods of generating splice resistant antibody genes.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: January 10, 2017
    Assignee: CATALENT PHARMA SOLUTIONS, INC.
    Inventors: Gregory T. Bleck, Dona York, Ian Collins
  • FUSION ANTIBODIES
    Publication number: 20100227394
    Abstract: The present invention provides novel antibodies. In particular, the present invention provides fusion antibodies comprising antibody heavy and light chain fusions. The present invention further provides multivalent antibodies comprising multiple fusion antibody chains. The present invention further provides methods of generating splice resistant antibody genes.
    Type: Application
    Filed: March 9, 2010
    Publication date: September 9, 2010
    Applicant: CATALENT PHARMA SOLUTIONS, INC.
    Inventors: Gregory T. Bleck, Dona York, Ian Collins
  • Fusion antibodies
    Patent number: 7696322
    Abstract: The present invention provides novel antibodies. In particular, the present invention provides fusion antibodies comprising antibody heavy and light chain fusions. The present invention further provides multivalent antibodies comprising multiple fusion antibody chains. The present invention further provides methods of generating splice resistant antibody genes.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: April 13, 2010
    Assignee: Catalent Pharma Solutions, Inc.
    Inventors: Gregory T. Bleck, Dona York, Ian Collins